AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Fresh Fund founder Zaki Djemal dies suddenly
2
“Within 10 years, there will be at least 10 more Israeli companies like Wiz”
3
Why did Zim’s CEO sell $40 million in shares before the $4.2 billion Hapag-Lloyd deal?
4
Wiz billionaires forming private family office to manage proceeds from $32 billion Google exit
5
Fresh from $32 billion exit, Wiz founders turn to Israeli media with $125 million bet on TV broadcaster
More news

Quarterly Reports

7 stories about Quarterly Reports
בצלאל מכליס נשיא אלביט מערכות

Elbit Systems records $60 million in write-offs due to Covid-19

26.10.20|James Spiro
The company had a tough quarter due to the reduced demand for aviation products, but still saw profits jump
ועידת התעשייה של ישראל גיל שויד מייסד מנכ"ל צ'ק פוינט

Check Point CEO says government should not aid the cyber industry

22.10.20|Sophie Shulman
The Nasdaq listed cybercompany reported $509 million in revenues in the third quarter of 2020
מנכ"ל טבע קאר שולץ קור שולץ קר שולץ מנכ"ל טבע פברואר 2018

Teva Quarterly Report Meets Analyst Expectations

07.11.19|Sophie Shulman
The Israeli drugmaker’s revenues dropped 6% in the third quarter of 2019 to $4.26 billion. Debt dropped by $1.8 billion to $26.9 billion
ברק עילם מנכל נייס

Nice's Quarterly Results Bolstered by Its Growing Cloud Business

09.08.18|CTech
The software company published its second-quarter reports for 2018 on Thursday, reporting a 10% year-over-year increase in revenues
אורי מוקדי סייברארק

CyberArk Announces 35% Year-Over-Year Revenue Increase for Second Quarter

08.08.18|Lilach Baumer
The information security company upped its guidance for 2018 after exceeding quarterly guidance on all metrics
מפעל טבע נתניה

There May Be a Silver Lining to Teva’s Woes

06.11.17|Eli Shimony
Analysts have lowered their target price for Teva following the company's less than stellar third quarter reports, but the company can still turn its luck around with new drugs and a willingness to tighten the belt
מנכ"ל טבע החדש קור שולץ 2

Generic Dependence Threatens Teva’s Ability to Haul Debt Load

05.11.17|Dror Reich and Lilach Baumer
Teva’s stock price dropped 18.7% last week after the company lowered its annual forecasts. On Friday, S&P changed the company’s outlook to negative